Abstract:Ubiquitination is a crucial posttranslational protein modification involved in a myriad of biological pathways. This modification is reversed by deubiquitinases (DUBs) that deconjugate the single ubiquitin (Ub) moiety or poly-Ub chains from substrates. In the past decade, tremendous efforts have been focused on targeting DUBs for drug discovery. However, most chemical compounds with inhibitory activity for DUBs suffer from mild potency and low selectivity. To overcome these obstacles, we developed a phage display-based protein engineering strategy for generating Ub variant (UbV) inhibitors, which was previously successfully applied to the Ub-specific protease (USP) family of cysteine proteases. In this work, we leveraged the UbV platform to selectively target STAMBP, a member of the JAB1/MPN/MOV34 (JAMM) metalloprotease family of DUB enzymes. We identified two UbVs (UbVSP.1 and UbVSP.3) that bind to STAMBP with high affinity but differ in their selectivity for the closely related paralog STAMBPL1. We determined the STAMBPL1-UbVSP.1 complex structure by X-ray crystallography, revealing hotspots of the JAMM-UbV interaction. Finally, we show that UbVSP.1 and UbVSP.3 are potent inhibitors of STAMBP isopeptidase activity, far exceeding the reported small-molecule inhibitor BC-1471. This work demonstrates that UbV technology is suitable to develop molecules as tools to target metalloproteases, which can be used to further understand the cellular function of JAMM family DUBs.

Accelerating inhibitor discovery for deubiquitinating enzymes

On the Study of Deubiquitinases: Using the Right Tools for the Job

Cell-Based Covalent-Capture Deubiquitinase Assay for Inhibitor Discovery

Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes

Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes

Deubiquitinase-targeting chimeras for targeted protein stabilization

Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade

Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1

A Strategy for Modulation of Enzymes in the Ubiquitin System

Recent advances in the development of deubiquitinases inhibitors as antitumor agents

An E1‐Catalyzed Chemoenzymatic Strategy to Isopeptide‐N‐Ethylated Deubiquitylase‐Resistant Ubiquitin Probes

Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes

Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of USP30 and a framework for DUB ligandability

Design of linked-domain protein inhibitors of UBE2D as tools to study cellular ubiquitination

Discovery of potent and selective activity-based probes (ABPs) for the deubiquitinating enzyme USP30

N‐Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1

A method to identify small molecule/protein pairs susceptible to protein ubiquitination

A Potent and Selective Inhibitor for the UBLCP1 Proteasome Phosphatase.

Detecting Active Deconjugating Enzymes with Genetically Encoded Activity-Based Ubiquitin and Ubiquitin-like Protein Probes

Uncovering the deubiquitinase activity landscape of breast cancer.

Discovery of electrophilic degraders that exploit SNAr chemistry